English | Español

Boehringer-Ingelheim
Carol Ostrow | Dec 15, 2017

Boehringer Ingelheim collaborations yield vaccine technology, cancer treatments
Ruth de Jauregui | Jun 14, 2017

Boehringer Ingelheim, Eli Lilly to collaborate in trial of empagliflozin for chronic kidney disease
Gene Johnson | Feb 25, 2017

Combination therapy targets lung cancer
Carol Ostrow | Feb 19, 2017

Partnership spurs efforts against COPD
Amanda Rupp | Jun 28, 2016

Boehringer Ingelheim board of managing directors introduces new member
Amanda Rupp | Jun 5, 2016

Boehringer Ingelheim, Inventiva collaborate for idiopathic pulmonary fibrosis treatments
Amanda Rupp | May 31, 2016

Boehringer Ingelheim to increase HIV/AIDS medication access
Amanda Rupp | May 25, 2016

BioMed X, Boehringer Ingelheim partner for psychiatric treatments

Trending
Patient Daily | Aug 18, 2025

Medfluence Advisors’ Greg Caesar to open ASCENT 2025 with keynote on digital practice growth
+ Pharmaceuticals
Patient Daily | Aug 18, 2025

Patients Come First spokesperson on 340B rebate model: ‘This rebate model provides the oversight that 340B has needed for decades’
+ Pharmaceuticals
Patient Daily | Aug 21, 2025

PhRMA director of public affairs on 340B rebate model: "Positive first step toward addressing hospital abuse of the 340B program
Patient Daily | Aug 21, 2025

SoCal Breathe Free doctor on balloon sinuplasty: ‘The procedure itself is pretty quick and effectiveness is pretty high’